NCT00539994View on ClinicalTrials.gov

Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Infections, Bacterial
Interventions
DRUG

retapamulin

200mg BID retapamulin 3 days

DRUG

Retapamulin

200mg BID retapamulin 5 days

DRUG

Placebo

200mg BID placebo 5 days

Trial Locations (4)

21225

GSK Investigational Site, Baltimore

92123

GSK Investigational Site, San Diego

96813

GSK Investigational Site, Honolulu

98418

GSK Investigational Site, Tacoma

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY